US Food and Drug Administration
Dr. Jason Moore received his Pharm.D. from Florida Agricultural & Mechanical University in Tallahassee, Florida. Afterwards, he completed a clinical pharmacology fellowship at Thomas Jefferson University where he conducted preclinical research investigating multiple sclerosis immunology, participated in clinical trial design and operation, and constructed models to assess human PK-PD data. He joined FDA in 2016 in the Division of Infectious Disease Pharmacology (then DCP4) supporting anti-infective, transplant, and ophthalmology drug development. He currently is an acting team lead in the Division of Cancer Pharmacology II.
Disclosure information not submitted.
Monday, January 10, 2022
2:00 PM – 3:00 PM ET
.png)